GlassScriptPhysician profile
Nabila Chowdhury
NPI 1609899418
$3,796.45
in general payments reported to CMS, 2019-2025
46 companies · $381 in 2025
The $381 reported for 2025 was less than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $989 · 2020: $425 · 2021: $393 · 2022: $271 · 2023: $742 · 2024: $595 · 2025: $381.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,692 · Education: $25.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,692.00 |
| Education | $25.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $382.29 | 2019-2025 | Enhertu, Imfinzi, Lynparza |
| Servier Pharmaceuticals LLC | $343.49 | 2021-2024 | |
| E.R. Squibb & Sons, L.L.C. | $322.94 | 2019-2025 | Eliquis, Opdivo |
| Novartis Pharmaceuticals Corporation | $274.03 | 2022-2025 | |
| Amgen INC. | $238.41 | 2019-2023 | Vectibix, Xgeva, Nplate |
| Celgene Corporation | $205.09 | 2019-2024 | Reblozyl |
| Merck Sharp & Dohme LLC | $195.12 | 2019-2025 | Keytruda, Lynparza |
| Daiichi Sankyo INC. | $168.68 | 2020-2025 | Enhertu, Datroway |
| Genzyme Corporation | $159.32 | 2020-2024 | |
| Janssen Biotech, INC. | $112.36 | 2019-2024 | Erleada, Carvykti |
| Seagen INC. | $104.11 | 2019-2023 | Tukysa |
| Puma Biotechnology, INC. | $87.69 | 2019-2025 | |
| Lilly USA, LLC | $78.86 | 2019-2025 | Verzenio, Jaypirca |
| Bayer Healthcare Pharmaceuticals INC. | $74.93 | 2019-2022 | |
| Eisai INC. | $72.77 | 2020-2024 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nabila Chowdhury listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.